[Effect of hydrochlorothiazide treatment on the secretion of insulin, glucagon and pancreatic polypeptide in patients with arterial hypertension].
D000328:Adult; D005260:Female; D005934:Glucagon / Q000378:metabolism; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism*; D010191:Pancreatic Polypeptide / Q000378:metabolism
D007328:Insulin; D006852:Hydrochlorothiazide; D010191:Pancreatic Polypeptide; D005934:Glucagon
Wpływ leczenia hydrochlorotiazydem na sekrecje insuliny, glukagonu i polipeptydu trzustkowego u chorych na nadciśnienie tetnicze.